Walleye Capital’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Walleye Capital’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-106,211	Closed	-$3.61K	–	5540
2023 Q2	$3.61K	Buy	106,211 +12,544	+13%	+$548	﹤0.01%	4077
2023 Q1	$6.51K	Sell	93,667 -331	-0.4%	-$28	﹤0.01%	3607
2022 Q4	$2.36K	Buy	93,998 +20,788	+28%	+$1.66K	﹤0.01%	2964
2022 Q3	$16K	Buy	73,210 +56,743	+345%	+$14K	﹤0.01%	2759
2022 Q2	$2K	Buy	+16,467	New	+$2.73K	﹤0.01%	2262

Other funds holding APGNW

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Walleye Capital's APGNW Position: Q3 2023 in Review

Walleye Capital sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 106,211 shares — an estimated $3.61K sold.

Walleye Capital first reported a position in APGNW in Q2 2022 and held it in 5 quarters. The position peaked at $16K in Q3 2022. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

Walleye Capital reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Walleye Capital sold 106,211 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $3.61K.
Walleye Capital first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q2 2022 and held it in 5 quarters.
Walleye Capital's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $16K in Q3 2022.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.